Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Association of v-Ha-ras transgene expression with development of erythroleukemia in Tg.AC transgenic mice.

Trempus CS, Ward S, Farris G, Malarkey D, Faircloth RS, Cannon RE, Mahler JF.

Am J Pathol. 1998 Jul;153(1):247-54.

2.
3.

Kinetics of wound-induced v-Ha-ras transgene expression and papilloma development in transgenic Tg.AC mice.

Cannon RE, Spalding JW, Trempus CS, Szczesniak CJ, Virgil KM, Humble MC, Tennant RW.

Mol Carcinog. 1997 Sep;20(1):108-14.

PMID:
9328441
4.
5.
6.

Age-dependent skin tumorigenesis and transgene expression in the Tg.AC (v-Ha-ras) transgenic mouse.

Battalora MS, Spalding JW, Szczesniak CJ, Cape JE, Morris RJ, Trempus CS, Bortner CD, Lee BM, Tennant RW.

Carcinogenesis. 2001 Apr;22(4):651-9.

PMID:
11285202
7.

Induction of transgene expression in Tg.AC(v-Ha-ras) transgenic mice concomitant with DNA hypomethylation.

Cannon RE, Spalding JW, Virgil KM, Faircloth RS, Humble MC, Lacks GD, Tennant RW.

Mol Carcinog. 1998 Apr;21(4):244-50.

PMID:
9585254
8.

Constitutive expression of GATA-1, EPOR, alpha-globin, and gamma-globin genes in myeloid clonogenic cells from juvenile chronic myelocytic leukemia.

Privitera E, SchirĂ² R, Longoni D, Ronchi A, Rambaldi A, Bernasconi S, Ottolenghi S, Masera G, Biondi A.

Blood. 1995 Jul 1;86(1):323-8.

9.

Transcriptional activation of human zeta 2 globin promoter by the alpha globin regulatory element (HS-40): functional role of specific nuclear factor-DNA complexes.

Zhang Q, Reddy PM, Yu CY, Bastiani C, Higgs D, Stamatoyannopoulos G, Papayannopoulou T, Shen CK.

Mol Cell Biol. 1993 Apr;13(4):2298-308.

10.

A farnesyl transferase inhibitor suppresses TPA-mediated skin tumor development without altering hyperplasia in the ras transgenic Tg.AC mouse.

Trempus CS, Bishop WR, Njoroge FG, Doll RJ, Battalora MS, Mahler JF, Haseman JK, Tennant RW.

Mol Carcinog. 2000 Jan;27(1):24-33.

PMID:
10642434
11.

Levels of GATA-1/GATA-2 transcription factors modulate expression of embryonic and fetal hemoglobins.

Ikonomi P, Noguchi CT, Miller W, Kassahun H, Hardison R, Schechter AN.

Gene. 2000 Dec 31;261(2):277-87.

PMID:
11167015
12.

Biologic significance of GATA-1 activities in Ras-mediated megakaryocytic differentiation of hematopoietic cell lines.

Matsumura I, Kawasaki A, Tanaka H, Sonoyama J, Ezoe S, Minegishi N, Nakajima K, Yamamoto M, Kanakura Y.

Blood. 2000 Oct 1;96(7):2440-50.

13.

Increased expression of GATA-1 and NFE-2 erythroid-specific transcription factors during aclacinomycin-mediated differentiation of human erythroleukemic cells.

Trentesaux C, Nyoung MN, Aries A, Morceau F, Ronchi A, Ottolenghi S, Jardillier JC, Jeannesson P.

Leukemia. 1993 Mar;7(3):452-7.

PMID:
8445949
14.
15.

Loss of palindromic symmetry in Tg.AC mice with a nonresponder phenotype.

Honchel R, Rosenzweig BA, Thompson KL, Blanchard KT, Furst SM, Stoll RE, Sistare FD.

Mol Carcinog. 2001 Feb;30(2):99-110.

PMID:
11241757
17.
19.
20.

Comparative expression of novel vascular endothelial growth factor/vascular permeability factor transcripts in skin, papillomas, and carcinomas of v-Ha-ras Tg.AC transgenic mice and FVB/N mice.

Tober KL, Cannon RE, Spalding JW, Oberyszyn TM, Parrett ML, Rackoff AI, Oberyszyn AS, Tennant RW, Robertson FM.

Biochem Biophys Res Commun. 1998 Jun 29;247(3):644-53.

PMID:
9647747

Supplemental Content

Support Center